首页> 外文期刊>Medical hypotheses >MMP-12 as a potential biomarker to forecast ischemic stroke in obese patients
【24h】

MMP-12 as a potential biomarker to forecast ischemic stroke in obese patients

机译:MMP-12作为肥胖患者缺血性卒中的潜在生物标志物

获取原文
获取原文并翻译 | 示例
       

摘要

Human health is threatened by obesity which causes the increasing incidence of various diseases, especially stroke. Ischemic stroke (IS) is mostly caused by the rupture of arterial plaque, whose instability is positively associated with matrix metalloproteinases (MMPs) that degrades extracellular matrix components. Studies have shown that matrix metalloproteinase-12 (MMP-12) may be involved in the pathogenesis of IS. Because of the higher incidence of stroke in obese patients than that in normal weight people, it is urgent for obesity to forecast stroke early. Considering high levels MMP-12 in obesity, we put forward that MMP-12 may be a potential biomarker for IS in obese patients.
机译:人类健康受到肥胖威胁的威胁,导致各种疾病的发病率越来越多,尤其是中风。 缺血性卒中(IS)主要由动脉斑块破裂引起的,其不稳定性与基质金属蛋白酶(MMP)呈正相关,可使细胞外基质组分降低。 研究表明,基质金属蛋白酶-12(MMP-12)可以参与是的发病机制。 由于肥胖患者中风的发病率较高,而不是正常的人,因此肥胖令人肥胖预测早期预测。 考虑到高水平的MMP-12在肥胖症中,我们提出了MMP-12可能是患者患者的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号